As shown in Figures 3A–F, BSMCs treated with polyI:C, had a significant increase in mRNA expression of IL-6, IFN-β1, CCL2 compared to untreated cells and this effect was observed to a higher extent in asthma and COPD BSMCs (p < 0.05). The gene discussed is CCL2; the disease is asthma.